Well, it’s not an all cash deal, so this one is a little more tricky. Now PFE’s stock price is part of the equation:
“The New York-based company will pay $50.19 — $33 in cash and 0.985 share of its stock — for each Wyeth share. That represents a 29 percent premium over Wyeth’s closing share [...]
Pfizer Inc. (PFE) said it is in talks to buy Wyeth (WYE). WSJ reports that they have been talking for months now and are not close to a deal yet:
“The two sides have been in discussions for months and a deal isn’t imminent, the people said. Given recent market volatility and overall economic uncertainty, the [...]
FRME announced that it completed the LNCB merger successfully on Dec. 31, 2008.
Here’s how I made out on the deal:
I get to choose either:
0.7004 shares of FRME for each of my LNCB. $22.21 * 0.7004 = $15.56. IOW, $15.56 for each share of LNCB if I sell my FRME stock soon after the deal [...]
Drugmaker Elan (ELN) said it wants to merge with someone and has hired advisers (Citigroup Global Markets) to review their options. Elan is Ireland’s largest drugmaker.
It is reviewing options such as a “…minority investment, an alliance, or a merger or sale of the company.”
The stock has been down and critics blame weak sales and company [...]
Abbott said it is buying Advanced Medical Optics (EYE) for $22/sh. EYE’s shares jumped from $8.85 on Friday to a current $21.44 today. Not much of an arbitrage scenario here, but I’ll keep an eye on it.
